What is the long-term picture for patients with EGFR-mutant NSCLC? episode artwork

EPISODE · Sep 15, 2021 · 13 MIN

What is the long-term picture for patients with EGFR-mutant NSCLC?

from touchPODCAST · host touchpodcast

touchMDT for touchONCOLOGY Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions and the role of the multidisciplinary team in keeping abreast of the latest data. The multidisciplinary team Medical oncologist: Dr David Planchard, France  Oncology nurse practitioner: Ms Beth Sandy, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/

Episode metadata supplied by the publisher feed · Published Sep 15, 2021

Embed this episode

Ready to play

What is the long-term picture for patients with EGFR-mutant NSCLC?

0:00 13:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 13 minutes long.

When was this touchPODCAST episode published?

This episode was published on September 15, 2021.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!